Dauten Family Center Operating Remotely

Faculty and staff of the Dauten Family Center for Bipolar Treament Innovation (DCBI) are currently operating remotely due to the COVID-19 crisis, but can be reached by phone or email during this time.

For urgent matters, please contact;

Administrative/Patient Coordinator, Rony Dieuseul, rdieuseul@partners.org
Program Manager, Phebe Olorunfemi, polorunfemi@mgh.harvard.edu

MGH Coronavirus Updates
https://www.massgeneral.org/news/coronavirus/coronavirus-latest-updates

We provide quality clinical care, conduct clinically informative research, and educate our colleagues, our patients, and the greater community about bipolar disorder

The Dauten Family Center for Bipolar Treatment Innovation specializes in expert pharmacological, neuromodulation, and psychosocial treatment of bipolar disorders. Psychiatrists, psychotherapists, practicum trainees, and research assistants have extensive experience conducting large-scale clinical trials. Research has been funded by the National Institute of Mental Health (NIMH), the Patient Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality (AHRQ), the American Foundation for Suicide Prevention, the Brain and Behavior Research Foundation, as well as pharmaceutical companies, and philanthropy. We welcome all opportunities to collaborate to find innovative treatments to get better outcomes that matter to people with bipolar disorder.